Denosumab, alendronate and zoledronate failure to suppress bone resorption markers in a woman affected by severe osteoporosis and subclinical hypercortisolism due to an adrenal adenoma: A case report

Autor:	Valentina Vicennati, Giulia Vandi, Paola Altieri, Uberto Pagotto, Guido Zavatta, Dalmazi Guido Di, Valentina Lo Preiato
Rok vydání:	2019
Předmět:	medicine.medical_specialty Denosumab business.industry Urology Medicine Adrenal adenoma Severe osteoporosis business medicine.disease Bone resorption Subclinical infection medicine.drug
Zdroj:	Endocrine Abstracts.
ISSN:	1479-6848
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::a13321bcfa6d00b69fe9ee3f8280b5bb https://doi.org/10.1530/endoabs.63.p515 Zobrazit plný text záznamu